A PHASE III, RANDOMIZED, OPEN-LABEL, COMPARATIVE, MULTI-CENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF PROGRAF?? (TACROLIMUS)/MMF, MODIFIED RELEASE (MR) TACROLIMUS/MMF AND NEORAL?? (CYCLOSPORINE)/MMF IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: 12 MONTH RESULTS.
2006 ◽
Vol 82
(Suppl 2)
◽
pp. 318